Drug intelligence / Profile preview

cantharidin collodion

Development stage
Unknown
Lead developer
Verrica Pharmaceuticals
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Cantharidin collodion is a topical pharmaceutical formulation containing 0.7% cantharidin in a film-forming vehicle composed of acetone, collodion, castor oil, and camphor. The active ingredient, cantharidin, is a vesicant derived from blister beetles (family Meloidae). It acts primarily through acantholysis—disrupting desmosomal attachments between epidermal cells—which leads to intraepidermal blister formation and subsequent exfoliation of lesions such as warts and molluscum contagiosum[8][4][5]. The basal layer of the skin remains intact during this process, minimizing scarring[8]. Cantharidin’s mechanism also involves inhibition of serine/threonine-protein phosphatases (notably protein phosphatase 2A), which may contribute to its cytotoxic effects[6][5]. This product is applied by healthcare professionals for the treatment of common warts (verruca vulgaris), periungual warts, plantar warts (in some cases), and molluscum contagiosum in adults and children above certain age thresholds[8][1].

Brand names
Cantharone
Other names
cantharidin collodioncantharidin 0.7% in collodion
02

Targets

KLK (Kallikrein-related peptidase (specifically KLK5 and KLK7))PP1 (Protein phosphatase 1)PP2A (Protein phosphatase 2A)

Beyond the preview

Go deeper on cantharidin collodion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cantharidin collodion.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call